These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 9341783)
21. Gender dimorphism of macrophage response to GMCSF and IL-4 for differentiation into dendritic cells. Gupta V; Singh SM Am J Reprod Immunol; 2008 Jul; 60(1):43-54. PubMed ID: 18593437 [TBL] [Abstract][Full Text] [Related]
22. Different tumours, transduced with different cytokine genes as G-CSF and IL-2, show inhibition of tumour take through neutrophil activation but differ in T cell functions. Stoppacciaro A; Forni G; Colombo MP Folia Biol (Praha); 1994; 40(1-2):89-99. PubMed ID: 7525363 [TBL] [Abstract][Full Text] [Related]
23. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand. Mach N; Gillessen S; Wilson SB; Sheehan C; Mihm M; Dranoff G Cancer Res; 2000 Jun; 60(12):3239-46. PubMed ID: 10866317 [TBL] [Abstract][Full Text] [Related]
24. Intrinsic ability of GM+IL-4 but not Flt3L-induced rat dendritic cells to promote allogeneic T cell hyporesponsiveness. Taieb A; Breitinger JJ; Unadkat JV; Shufesky WJ; Morelli AE; Thomson AW; Lee WP; Feili-Hariri M Clin Immunol; 2007 May; 123(2):176-89. PubMed ID: 17276735 [TBL] [Abstract][Full Text] [Related]
25. Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7-1 (CD80) and B7-2 (CD86) expression. Mitra RS; Judge TA; Nestle FO; Turka LA; Nickoloff BJ J Immunol; 1995 Mar; 154(6):2668-77. PubMed ID: 7533180 [TBL] [Abstract][Full Text] [Related]
26. Contrasting effects of TGF-beta 1 and TNF-alpha on the development of dendritic cells from progenitors in mouse bone marrow. Yamaguchi Y; Tsumura H; Miwa M; Inaba K Stem Cells; 1997; 15(2):144-53. PubMed ID: 9090791 [TBL] [Abstract][Full Text] [Related]
27. Effect of GM-CSF and IL-2 co-expression on the anti-tumor immune response. Lee SG; Heo DS; Yoon SJ; Jee YS; Kang JO; Kim K; Kim CD; Sung MW; Kim NK Anticancer Res; 2000; 20(4):2681-6. PubMed ID: 10953343 [TBL] [Abstract][Full Text] [Related]
28. [In vitro inducing differentiation of bone marrow mononuclear cells of chronic myeloid leukemia]. Wu CY; Zhang LS; Zhang YF; Chai Y; Yi LC; Song FX Ai Zheng; 2005 Apr; 24(4):425-31. PubMed ID: 15820064 [TBL] [Abstract][Full Text] [Related]
29. Dendritic cells as the terminal stage of monocyte differentiation. Palucka KA; Taquet N; Sanchez-Chapuis F; Gluckman JC J Immunol; 1998 May; 160(9):4587-95. PubMed ID: 9574566 [TBL] [Abstract][Full Text] [Related]
32. Granulocyte/macrophage colony-stimulating factor and interleukin-4-induced dendritic cells. Hikino H; Kasono K; Kanzaki M; Kai T; Konishi F; Kawakami M Anticancer Res; 2004; 24(3a):1609-15. PubMed ID: 15274330 [TBL] [Abstract][Full Text] [Related]
33. Development of dendritic cells in culture from human and murine thymic precursor cells. Kelly KA; Lucas K; Hochrein H; Metcalf D; Wu L; Shortman K Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):43-54. PubMed ID: 11292259 [TBL] [Abstract][Full Text] [Related]
34. Dendritic cells genetically engineered to simultaneously express endogenous tumor antigen and granulocyte macrophage colony-stimulating factor elicit potent therapeutic antitumor immunity. Nakamura M; Iwahashi M; Nakamori M; Ueda K; Matsuura I; Noguchi K; Yamaue H Clin Cancer Res; 2002 Aug; 8(8):2742-9. PubMed ID: 12171908 [TBL] [Abstract][Full Text] [Related]
35. GM-CSF promotes differentiation of human dendritic cells and T lymphocytes toward a predominantly type 1 proinflammatory response. Eksioglu EA; Mahmood SS; Chang M; Reddy V Exp Hematol; 2007 Aug; 35(8):1163-71. PubMed ID: 17562355 [TBL] [Abstract][Full Text] [Related]
36. GM-CSF expands dendritic cells and their progenitors in mouse liver. Pillarisetty VG; Miller G; Shah AB; DeMatteo RP Hepatology; 2003 Mar; 37(3):641-52. PubMed ID: 12601362 [TBL] [Abstract][Full Text] [Related]
37. TLR7 ligand augments GM-CSF-initiated antitumor immunity through activation of plasmacytoid dendritic cells. Narusawa M; Inoue H; Sakamoto C; Matsumura Y; Takahashi A; Inoue T; Watanabe A; Miyamoto S; Miura Y; Hijikata Y; Tanaka Y; Inoue M; Takayama K; Okazaki T; Hasegawa M; Nakanishi Y; Tani K Cancer Immunol Res; 2014 Jun; 2(6):568-80. PubMed ID: 24830413 [TBL] [Abstract][Full Text] [Related]
38. Modulation of cytokine expression in mouse dendritic cell clones. Granucci F; Girolomoni G; Lutz MB; Foti M; Marconi G; Gnocchi P; Nolli L; Ricciardi-Castagnoli P Eur J Immunol; 1994 Oct; 24(10):2522-6. PubMed ID: 7925580 [TBL] [Abstract][Full Text] [Related]
39. IL-3 in dendritic cell development and function: a comparison with GM-CSF and IL-4. Lutz MB Immunobiology; 2004; 209(1-2):79-87. PubMed ID: 15481143 [TBL] [Abstract][Full Text] [Related]
40. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. Zitvogel L; Mayordomo JI; Tjandrawan T; DeLeo AB; Clarke MR; Lotze MT; Storkus WJ J Exp Med; 1996 Jan; 183(1):87-97. PubMed ID: 8551248 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]